The introduction of combination antiretroviral therapy (cART) in 1996 ushered a new era for people living with human immunodeficiency virus (HIV) (PLWH) [1], with HIV shifting from being an opportunistic and fatal disease to being a chronic illness associated with accelerated development of cardiovascular disease (CVD)
Fogacci F, B.C. (2022). People living with human immunodeficiency virus: Cardiovascular risk screening for an early and effective risk management. ATHEROSCLEROSIS, 353, 28-29 [10.1016/j.atherosclerosis.2022.06.001].
People living with human immunodeficiency virus: Cardiovascular risk screening for an early and effective risk management.
Borghi CSecondo
Conceptualization
;Cicero AFGUltimo
Supervision
2022
Abstract
The introduction of combination antiretroviral therapy (cART) in 1996 ushered a new era for people living with human immunodeficiency virus (HIV) (PLWH) [1], with HIV shifting from being an opportunistic and fatal disease to being a chronic illness associated with accelerated development of cardiovascular disease (CVD)File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
